| Financial Year |
March 31 2023 |
| Monetary Funds |
10,985,707,000.00 |
| Held-for-trading Financial Assets |
277,819,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,376,699,000.00 |
| Advances to Suppliers |
1,358,784,000.00 |
| Other Receivables |
7,522,087,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
4,853,000.00 |
| Inventories |
1,288,729,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,532,209,000.00 |
| Total Current Assets |
24,342,034,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
49,155,000.00 |
| Investment Properties |
2,819,521,000.00 |
| Fixed Assetes |
39,815,739,000.00 |
| Under-construction Projects |
5,057,144,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,554,085,000.00 |
| R&D expenses |
-- |
| Goodwill |
843,981,000.00 |
| Long-Term Deferred and Prepaid Expenses |
961,153,000.00 |
| Deferred Income Tax Assets |
6,363,460,000.00 |
| Other Non-Current Assets |
2,385,287,000.00 |
| Sub-Total of Non-Current Assets |
114,957,115,000.00 |
| Total Assets |
139,299,149,000.00 |
| Short-Term Loans |
79,562,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
992,147,000.00 |
| Accounts Payable |
8,590,690,000.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,101,893,000.00 |
| Taxes Payable |
1,192,664,000.00 |
| Interest Payable |
841,103,000.00 |
| Dividend Payable |
1,567,000.00 |
| Other payables |
1,984,472,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,777,605,000.00 |
| Other Current Liabilities |
115,705,000.00 |
| Sub-Total of Current Liabilities |
32,639,792,000.00 |
| Long-term Loans |
46,517,668,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
900,675,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
9,274,131,000.00 |
| Deferred Income Tax Liabilities |
181,410,000.00 |
| Other Non-Current Liabilities |
768,940,000.00 |
| Sub-Total of Non-Current Liabilities |
105,123,708,000.00 |
| Total Liabilities |
137,763,500,000.00 |
| Paid-In Capital(Or Share Stock) |
43,215,632,000.00 |
| Capital Surplus |
38,609,805,000.00 |
| Surplus Reserve |
1,672,872,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-75,738,262,000.00 |
| Minority Stockholder's Interest |
-777,315,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,312,964,000.00 |
| Owner's Equity（Stockholder's Equity） |
1,535,649,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
139,299,149,000.00 |
